Blood Levels of Tenofovir Gel in HIV Uninfected Pregnant Women Planning Cesarean Delivery

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

January 31, 2010

Conditions

HIV Infections

Interventions

DRUG

Tenofovir 1% vaginal gel

topical gel containing 1% tenofovir

Trial Locations (1)

Pitt CRS, Pittsburgh

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Microbicide Trials Network

NETWORK

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00540605 - Blood Levels of Tenofovir Gel in HIV Uninfected Pregnant Women Planning Cesarean Delivery | Biotech Hunter | Biotech Hunter